Serving hundreds of leading biopharmaceutical companies globally:

Generated: December 18, 2018

DrugPatentWatch Database Preview

CIMZIA Drug Profile

« Back to Dashboard

Summary for Tradename: CIMZIA

Patents:	59
Applicants:	1
BLAs:	1
Suppliers: see list	1
Drug Prices:	Drug price information for CIMZIA

Pharmacology for CIMZIA

Mechanism of Action	Tumor Necrosis Factor Receptor Blocking Activity

US Patents for CIMZIA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Ucb Inc	CIMZIA	certolizumab pegol	INJECTABLE; INJECTION	125160	001	2008-04-22	➤ Sign Up	LegoChem Biosciences, Inc. (Daejeon, KR)	➤ Sign Up	RX		search
Ucb Inc	CIMZIA	certolizumab pegol	INJECTABLE; INJECTION	125160	001	2008-04-22	➤ Sign Up	SANOFI BIOTECHNOLOGY (Paris, FR) REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY)	➤ Sign Up	RX		search
Ucb Inc	CIMZIA	certolizumab pegol	INJECTABLE; INJECTION	125160	001	2008-04-22	➤ Sign Up	LegoChem Biosciences, Inc. (Daejeon, KR)	➤ Sign Up	RX		search
Ucb Inc	CIMZIA	certolizumab pegol	INJECTABLE; INJECTION	125160	001	2008-04-22	➤ Sign Up	University of Maryland, Baltimore (Baltimore, MA)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for CIMZIA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Germany	69830570	➤ Sign Up
World Intellectual Property Organization (WIPO)	2011066374	➤ Sign Up
China	102066974	➤ Sign Up
Singapore	189391	➤ Sign Up
Country	Document Number	Estimated Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte

Merck

AstraZeneca

Healthtrust

Harvard Business School

Fish and Richardson

Federal Trade Commission

Mallinckrodt

UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.